Discounted Cash Flow Rating

Strong Sell

Return on Equity Rating

Strong Sell

Debt to Equity Rating

Buy

Price to Earnings Rating

Buy

Analyst Rating

Sell

Simple Moving Average

Neutral

Exponential Moving Average

Neutral

Relative Strength Index

Buy

Standard Deviation

Sell

Williams %R

Strong Buy

Average Directional Index

Strong Sell

Insider Trading

Strong Buy

Wall Street Data Solutions Rating

Neutral

B

Passage Bio, Inc. Common Stock (PASG)

Biological Products, (no Disgnostic Substances)

https://www.passagebio.com

Passage Bio Inc is a genetic medicines company. The company is focused on developing transformative therapies for rare, monogenic CNS disorders. It has pipeline products such as GM1 Gangliosidosis, Frontotemporal dementia, and Krabbe Disease.

ONE COMMERCE SQUARE, 2005 MARKET STREET, 39TH FLOOR
PHILADELPHIA, PA

Current Price

---.--

% Change Today

0.00%

Change Amt. Today

0.00

Active Status

Active

Listing Date

02/28/2020

Market Cap

48,215,554

Shares Outstanding

54,820,000

Weighted SO

54,819,638

Total Employees

N/A

Upcoming Earnings

08/05/2024

Similar Tickers

BDTX --.--%

RVMD --.--%

FIXX --.--%

STOK --.--%

CABA --.--%

Beta

1.1980

Last Div

0.0000

Range

0.575-1.79

Chg

0.0006

Avg Vol

206230

Mkt Cap

48215554

Exch

NASDAQ

Country

US

Phone

267 866 0311

DCF Diff

0.8903

DCF

-0.0838

Div Yield

0.0000

P/S

8.1555

EV Multiple

-0.6223

P/FV

0.5317

Div Yield %

0.0000

P/E

-0.6288

PEG

-0.0243

Payout

0.0000

Current Ratio

7.6706

Quick Ratio

7.6706

Cash Ratio

2.0000

DSO

0.0000

DIO

0.0000

Op Cycle

0.0000

DPO

66.4122

CCC

-66.4122

Gross Margin

0.4227

Op Margin

-13.8884

Pretax Margin

-12.9516

Net Margin

-12.9516

Eff Tax Rate

-0.0330

ROA

-0.6106

ROE

-0.7073

ROCE

-0.7266

NI/EBT

1.0000

EBT/EBIT

0.9326

EBIT/Rev

-13.8884

Debt Ratio

0.2086

D/E

0.2888

LT Debt/Cap

0.1987

Total Debt/Cap

0.2241

Int Coverage

-53.1443

CF/Debt

-2.7052

Equity Multi

1.3847

Rec Turnover

0.0000

Pay Turnover

5.4960

Inv Turnover

0.0000

FA Turnover

0.1979

Asset Turnover

0.0471

OCF/Share

-1.1469

FCF/Share

-1.1472

Cash/Share

1.4878

OCF/Sales

-11.9662

FCF/OCF

1.0002

CF Coverage

-2.7052

ST Coverage

-19.1148

CapEx Coverage

-4161.4118

Div&CapEx Cov

-4161.4118

P/BV

0.5317

P/B

0.5317

P/S

8.1555

P/E

-0.6288

P/FCF

-0.6814

P/OCF

-0.6806

P/CF

-0.6806

PEG

-0.0243

P/S

8.1555

EV Multiple

-0.6223

P/FV

0.5317

DPS

0.0000

Latest Headlines (EST)

GlobeNewswire Inc. Nov 17, 16:30 Passage Bio Announces Inducement Grant Under Nasdaq Listing Rule 5635(C)(4) Benzinga Nov 14, 07:38 Monday.Com To Rally Around 20%? Here Are 10 Top Analyst Forecasts For Tuesday

Revenue Product Segmentation